TNFRSF10A and neoplasm: However, as demonstrated here using TRAIL-deficient isogenic cell lines, and in a recently published work using a siRNA approach [8], TRAIL-R2 but not TRAIL-R1, can induce tumor cell motility and contribute to metastasis in vivo.